Curious to see your top suppliers emissions?
Book a demo for a pilot project
Fosun Pharma, officially known as Shanghai Fosun Pharmaceutical (Group) Co., Ltd., is a prominent player in the global healthcare sector, headquartered in Shanghai, China. Established in 1994, the company has made significant strides in the pharmaceutical and healthcare industries, focusing on research and development, manufacturing, and distribution of a diverse range of medical products and services.
Operating primarily in China and expanding its reach internationally, Fosun Pharma is recognised for its innovative approach to drug development and healthcare solutions. The company offers a unique portfolio that includes prescription drugs, vaccines, and diagnostic products, setting itself apart through strategic partnerships and a commitment to quality. With a strong market position, Fosun Pharma has achieved notable milestones, including successful collaborations and acquisitions that enhance its global footprint in the healthcare landscape.
44
DitchCarbon score
+8 vs industry average
Fosun Pharma’s score of 44 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Fosun Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Business Services is among the most carbon-intensive industries
Industry performance
0.146
20182025
The Business Services industry has reduced its overall emissions by 25% since 2018
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Fosun Pharma's reported carbon emissions
Fosun Pharma, headquartered in China, reported total carbon emissions of approximately 929.4 million kg CO2e in 2024. This includes about 184.0 million kg CO2e from Scope 1 emissions, 653.6 million kg CO2e from Scope 2 emissions, and 91.8 million kg CO2e from Scope 3 emissions.
Looking back, their total emissions were approximately 960.9 million kg CO2e in 2023, 949.5 million kg CO2e in 2022, 900.1 million kg CO2e in 2021, 827.9 million kg CO2e in 2020, 758.1 million kg CO2e in 2019, and 786.4 million kg CO2e in 2018.
Fosun Pharma has set near-term intensity reduction targets. They aim to reduce comprehensive energy consumption intensity by 10% by 2025 compared to 2020, targeting 2.287 GJ/RMB10,000 revenue. Additionally, they plan to reduce carbon emission intensity (Scope 2) by 15% by 2025 compared to 2020, aiming for 0.23 tonnes CO2e/RMB10,000 revenue. The company also references the International Energy Agency's plan to achieve net zero emissions by 2050. All reported emissions data and reduction targets are directly from Fosun Pharma and are not cascaded from a parent or related organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Fosun Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Fosun Pharma5 months ago
44
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more